{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T17:10:06Z","timestamp":1787764206994,"version":"build-2784847793"},"reference-count":95,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002850","name":"FONDECYT","doi-asserted-by":"publisher","award":["1100299"],"award-info":[{"award-number":["1100299"]}],"id":[{"id":"10.13039\/501100002850","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002850","name":"FONDECYT","doi-asserted-by":"publisher","award":["1130053"],"award-info":[{"award-number":["1130053"]}],"id":[{"id":"10.13039\/501100002850","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002848","name":"CONICYT","doi-asserted-by":"publisher","award":["24121153"],"award-info":[{"award-number":["24121153"]}],"id":[{"id":"10.13039\/501100002848","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002848","name":"CONICYT","doi-asserted-by":"publisher","award":["21100275"],"award-info":[{"award-number":["21100275"]}],"id":[{"id":"10.13039\/501100002848","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Steroids"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.steroids.2017.08.007","type":"journal-article","created":{"date-parts":[[2017,8,18]],"date-time":"2017-08-18T16:09:25Z","timestamp":1503072565000},"page":"85-91","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["Endometrium and steroids, a pathologic overview"],"prefix":"10.1016","volume":"126","author":[{"given":"Francisca","family":"Plaza-Parrochia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Valladares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarita","family":"Vega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.steroids.2017.08.007_b0005","first-page":"1379","article-title":"Presence of estrogen receptor beta in the human endometrium through the cycle: expression in glandular, stromal, and vascular cells","volume":"86","author":"Lecce","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.steroids.2017.08.007_b0010","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/humupd\/dmm009","article-title":"Estrogen and the endometrium: lessons learned from gene expression profiling in rodents and human","volume":"13","author":"Groothuis","year":"2007","journal-title":"Hum. Reprod. Update"},{"issue":"7","key":"10.1016\/j.steroids.2017.08.007_b0015","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1016\/j.fertnstert.2011.02.051","article-title":"Estrogen and progesterone receptor isoform distribution through the menstrual cycle in uteri with and without adenomyosis","volume":"95","author":"Mehasseb","year":"2011","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.steroids.2017.08.007_b0020","first-page":"1","article-title":"The roles of sex steroid receptor coregulators in cancer","author":"Gao","year":"2002","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.steroids.2017.08.007_b0025","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.bpobgyn.2016.03.008","article-title":"Polycystic ovary syndrome: endometrial markers","volume":"37","author":"Piltonen","year":"2016","journal-title":"Best. Pract. Res. Clin. Obstet. Gynaecol."},{"key":"10.1016\/j.steroids.2017.08.007_b0030","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.diff.2016.05.006","article-title":"Sox9 overexpression in uterine epithelia induces endometrial gland hyperplasia","volume":"92","author":"Gonzalez","year":"2016","journal-title":"Differentiation"},{"key":"10.1016\/j.steroids.2017.08.007_b0035","first-page":"296","article-title":"Role of exogenous and endogenous hormones in endometrial cancer review of the evidence and research perspectives","author":"Akhmedkhanov","year":"2001","journal-title":"Endometrial Cancer"},{"key":"10.1016\/j.steroids.2017.08.007_b0040","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3322\/caac.21208","article-title":"Cancer statistics, 2014","volume":"64","author":"Siegel","year":"2014","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.steroids.2017.08.007_b0045","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1002\/cncr.30094","article-title":"Endometrial cancer: not your grandmother\u2019s cancer","volume":"122","author":"McAlpine","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.steroids.2017.08.007_b0050","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1017\/S0007114515004171","article-title":"Dietary inflammatory index and endometrial cancer risk in an Italian case\u2013control study","volume":"115","author":"Shivappa","year":"2016","journal-title":"Br. J. Nut."},{"key":"10.1016\/j.steroids.2017.08.007_b0055","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0140-6736(05)67063-8","article-title":"Endometrial cancer","volume":"366","author":"Amant","year":"2005","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.steroids.2017.08.007_b0060","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/modpathol.3880062","article-title":"Immunohistochemical profile of endometrial adenocarcinoma: a study of 61 cases and review of the literature","volume":"13","author":"Kounelis","year":"2000","journal-title":"Mod. Pathol."},{"issue":"4","key":"10.1016\/j.steroids.2017.08.007_b0065","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.tem.2011.01.005","article-title":"Progesterone: the ultimate endometrial tumor suppressor","volume":"22","author":"Yang","year":"2011","journal-title":"Trends Endocrinol. Metab."},{"issue":"8","key":"10.1016\/j.steroids.2017.08.007_b0070","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/ng.3602","article-title":"The genomic landscape and evolution of endometrial carcinoma progression and abdominopelvic metastasis","volume":"48","author":"Gibson","year":"2016","journal-title":"Nature Genetics"},{"issue":"1","key":"10.1016\/j.steroids.2017.08.007_b0075","doi-asserted-by":"crossref","first-page":"506","DOI":"10.18632\/oncotarget.13471","article-title":"Is the positivity of estrogen receptor or progesterone receptor different between type 1 and type 2 endometrial cancer?","volume":"8","author":"Shen","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.steroids.2017.08.007_b0080","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.humpath.2016.09.021","article-title":"Association of ovarian hyperthecosis with endometrial polyp, endometrial hyperplasia, and endometrioid adenocarcinoma in postmenopausal women: a clinicopathological study of 238 cases","volume":"59","author":"Zhang","year":"2016","journal-title":"Hum. Pathol."},{"issue":"2","key":"10.1016\/j.steroids.2017.08.007_b0085","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1210\/er.2001-0031","article-title":"Endocrine and intracrine sources of androgens in women: inhibition of breast cancer and other roles of androgens and their precursor dehydroepiandrosterone","volume":"24","author":"Labrie","year":"2003","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.steroids.2017.08.007_b0090","first-page":"123","article-title":"The selective estrogen enzyme modulators in breast cancer: a review","volume":"1654","author":"Pasqualini","year":"2004","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.steroids.2017.08.007_b0095","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jsbmb.2008.11.004","article-title":"Comparable amounts of sex steroids are made outside the gonads in men and women: strong lesson for hormone therapy of prostate and breast cancer","volume":"113","author":"Labrie","year":"2009","journal-title":"J. Steroid. Biochem. Mol. Biol."},{"key":"10.1016\/j.steroids.2017.08.007_b0100","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jsbmb.2013.05.017","article-title":"Assessment of steroidogenesis and steroidogenic enzyme functions","volume":"137","author":"Luu-The","year":"2013","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.steroids.2017.08.007_b0105","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jsbmb.2014.09.012","article-title":"Intracrinology in action: importance of extragonadal sex steroid biosynthesis and inactivation in peripheral tissues in both women and men","volume":"145","author":"Labrie","year":"2015","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"33","key":"10.1016\/j.steroids.2017.08.007_b0110","doi-asserted-by":"crossref","first-page":"13728","DOI":"10.1073\/pnas.1107898108","article-title":"Dihydrotestosterone synthesis bypasses testosterone to drive castration-resistant prostate cancer","volume":"108","author":"Chang","year":"2011","journal-title":"PNAS"},{"key":"10.1016\/j.steroids.2017.08.007_b0115","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.beem.2010.09.008","article-title":"Prostate diseases \u2013 role of sex steroids and their inhibitors","volume":"25","author":"Wel\u00e9n","year":"2011","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"issue":"11","key":"10.1016\/j.steroids.2017.08.007_b0120","doi-asserted-by":"crossref","first-page":"e77407","DOI":"10.1371\/journal.pone.0077407","article-title":"Characterization of prostate cancer bone metastases according to expression levels of steroidogenic enzymes and androgen receptor splice variants","volume":"8","author":"Jernberg","year":"2013","journal-title":"Plus One"},{"key":"10.1016\/j.steroids.2017.08.007_b0125","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jsbmb.2007.09.012","article-title":"Intracrinology of estrogens and androgens in breast carcinoma","volume":"108","author":"Sasano","year":"2008","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.steroids.2017.08.007_b0130","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/j.1440-1827.2009.02444.x","article-title":"In situ estrogen production and its regulation in human breast carcinoma: from endocrinology to intracrinology","volume":"59","author":"Sasano","year":"2009","journal-title":"Pathol. Int."},{"issue":"6","key":"10.1016\/j.steroids.2017.08.007_b0135","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1186\/bcr936","article-title":"Metabolic inactivation of estrogens in breast tissue by UDPglucuronosyltransferase enzymes: an overview","volume":"6","author":"Guillemette","year":"2004","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.steroids.2017.08.007_b0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2010.09.008","article-title":"Steroid hormone receptors in cancer development: a target for cancer therapeutics","volume":"300","author":"Ahmad","year":"2011","journal-title":"Cancer Lett."},{"issue":"8","key":"10.1016\/j.steroids.2017.08.007_b0145","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1158\/1055-9965.EPI-09-0312","article-title":"Circulating estrogen metabolites and risk for breast cancer in premenopausal women","volume":"18","author":"Arslan","year":"2009","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.steroids.2017.08.007_b0150","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1056\/NEJM197606032942303","article-title":"Increasing incidence of endometrial cancer in the United States","volume":"294","author":"Weiss","year":"1976","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.steroids.2017.08.007_b0155","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.maturitas.2016.05.013","article-title":"Hormone replacement therapy and the risk of endometrial cancer: a systematic review","volume":"91","author":"Sj\u00f6gren","year":"2016","journal-title":"Maturitas"},{"key":"10.1016\/j.steroids.2017.08.007_b0160","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.ygyno.2016.06.006","article-title":"Association between differential gene expression and body mass index among endometrial cancers from The Cancer Genome Atlas Project","volume":"142","author":"Roque","year":"2016","journal-title":"Gynecol. Oncol."},{"issue":"8","key":"10.1016\/j.steroids.2017.08.007_b0165","doi-asserted-by":"crossref","first-page":"e1002081","DOI":"10.1371\/journal.pmed.1002081","article-title":"Duration of adulthood overweight, obesity, and cancer risk in the women\u2019s health initiative: a longitudinal study from the United States","volume":"13","author":"Arnold","year":"2016","journal-title":"PLoS Med."},{"key":"10.1016\/j.steroids.2017.08.007_b0170","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.ygyno.2015.10.020","article-title":"Body mass index and mortality in endometrial cancer: a systematic review and meta-analysis","volume":"140","author":"Alvarez Secord","year":"2016","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.steroids.2017.08.007_b0175","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ygyno.2009.12.022","article-title":"The effect of overweight and obesity on proliferation and activation of AKT and ERK in human endometria","volume":"117","author":"Villavicencio","year":"2010","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.steroids.2017.08.007_b0180","doi-asserted-by":"crossref","first-page":"R55","DOI":"10.1530\/JME-15-0254","article-title":"What\u2019s new in estrogen receptor action in the female reproductive tract","volume":"56","author":"Hewitt","year":"2016","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.steroids.2017.08.007_b0185","doi-asserted-by":"crossref","first-page":"4387","DOI":"10.1210\/jc.2006-0284","article-title":"Circulating bioactive androgens in midlife women","volume":"91","author":"Chen","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.steroids.2017.08.007_b0190","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1210\/en.2015-2032","article-title":"A role for androgens in epithelial proliferation and formation of glands in the mouse uterus","volume":"157","author":"Simitsidellis","year":"2016","journal-title":"Endocrinology"},{"issue":"31","key":"10.1016\/j.steroids.2017.08.007_b0195","doi-asserted-by":"crossref","first-page":"49289","DOI":"10.18632\/oncotarget.10334","article-title":"Androgen receptor as potential therapeutic target in metastatic endometrial cancer","volume":"7","author":"Tangen","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.steroids.2017.08.007_b0200","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.steroids.2014.07.008","article-title":"The role of androst-5-ene-3\u03b2,17\u03b2-diol (androstenediol) in cell proliferation in endometrium of women with polycystic ovary syndrome","volume":"89","author":"Plaza-Parrochia","year":"2014","journal-title":"Steroids"},{"key":"10.1016\/j.steroids.2017.08.007_b0205","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S0015-0282(16)59706-4","article-title":"The inhibitory effects of danazol, danazol metabolites, gestrinone, and testosterone on the growth of human endometrial cells in vitro","volume":"49","author":"Rose","year":"1988","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.steroids.2017.08.007_b0210","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/BF02134072","article-title":"Effect of progestins, androgens, estrogens and antiestrogens on 3H-thymidine uptake by human endometrial and endosalpinx cells in vitro","volume":"240","author":"Neulen","year":"1987","journal-title":"Arch. Gynecol."},{"issue":"2","key":"10.1016\/j.steroids.2017.08.007_b0215","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.beem.2006.03.005","article-title":"Endometrium in PCOS: implantation and predisposition to endocrine CA","volume":"20","author":"Giudice","year":"2006","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.steroids.2017.08.007_b9000","doi-asserted-by":"crossref","first-page":"e0148912","DOI":"10.1371\/journal.pone.0148912","article-title":"Inverse relationship between progesterone receptor and myc in endometrial cancer","volume":"11","author":"Kavlashvili","year":"2016","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.steroids.2017.08.007_b9005","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1210\/en.2007-0756","article-title":"The regulation and function of the forkhead transcription factor, Forkhead box O1, is dependent on the progesterone receptor in endometrial carcinoma","volume":"149","author":"Ward","year":"2008","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.steroids.2017.08.007_b9010","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ygyno.2015.10.023","article-title":"Downregulation of FOXO1 mRNA levels predicts treatment failure in patients with endometrial pathology conservatively managed with progestin-containing intrauterine devices","volume":"140","author":"Reyes","year":"2016","journal-title":"Gynecol. Oncol."},{"issue":"3","key":"10.1016\/j.steroids.2017.08.007_b9015","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s12672-011-0065-7","article-title":"Progesterone receptor-B induction of BIRC3 protects endometrial cancer cells from AP1-59-mediated apoptosis","volume":"2","author":"Neubauer","year":"2011","journal-title":"Horm. Cancer"},{"key":"10.1016\/j.steroids.2017.08.007_b9020","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S1877-1173(09)87002-6","article-title":"Progesterone receptor action in leiomyoma and endometrial cancer","volume":"87","author":"Kim","year":"2009","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"issue":"1","key":"10.1016\/j.steroids.2017.08.007_b9025","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1210\/er.2012-1043","article-title":"Progesterone action in endometrial cancer, endometriosis, uterine fibroids, and breast cancer","volume":"34","author":"Kim","year":"2013","journal-title":"Endocr. Rev."},{"issue":"7","key":"10.1016\/j.steroids.2017.08.007_b0220","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.tem.2015.05.001","article-title":"Novel insights in SHBG regulation and clinical implications","volume":"26","author":"Sim\u00f3","year":"2015","journal-title":"Trends Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.steroids.2017.08.007_b0225","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1177\/1933719114561552","article-title":"Obesity and PCOS: the effect of metabolic derangements on endometrial receptivity at the time of implantation","volume":"22","author":"Schulte","year":"2015","journal-title":"Reprod. Sci."},{"key":"10.1016\/j.steroids.2017.08.007_b0230","doi-asserted-by":"crossref","first-page":"R219","DOI":"10.1530\/REP-14-0435","article-title":"Adipose tissue dysfunction, adipokines, and low-grade chronic inflammation in polycystic ovary syndrome","volume":"149","author":"Spritzer","year":"2015","journal-title":"Reproduction"},{"key":"10.1016\/j.steroids.2017.08.007_b0235","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1038\/ijo.2016.154","article-title":"Proinflammatory environment and role of TNF-\u03b1 in endometrial function of obese women having polycystic ovarian syndrome","volume":"40","author":"Or\u00f3stica","year":"2016","journal-title":"Int. J. Obesity"},{"issue":"2","key":"10.1016\/j.steroids.2017.08.007_b0240","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.fertnstert.2006.06.038","article-title":"Sex hormone-binding globulin expression in the endometria of women with polycystic ovary syndrome","volume":"87","author":"Maliqueo","year":"2007","journal-title":"Fertil. Steril."},{"issue":"12","key":"10.1016\/j.steroids.2017.08.007_b0245","doi-asserted-by":"crossref","first-page":"4546","DOI":"10.1210\/jc.2007-1549","article-title":"Glucose intolerance in polycystic ovary syndrome\u2014a position statement of the androgen excess society","volume":"92","author":"Salley","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"299","key":"10.1016\/j.steroids.2017.08.007_b0250","first-page":"e1","article-title":"Prevalence of polycystic ovary syndrome among the privately insured, United States, 2003\u20132008","volume":"207","author":"Okoroh","year":"2012","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.steroids.2017.08.007_b0255","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/1477-7827-10-96","article-title":"Polycystic ovary syndrome in Salvador, Brazil: a prevalence study in primary healthcare","volume":"10","author":"Gabrielli","year":"2012","journal-title":"Reprod. Biol. Endocrinol."},{"issue":"1","key":"10.1016\/j.steroids.2017.08.007_b0260","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","author":"The Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2004","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.steroids.2017.08.007_b0265","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.fertnstert.2008.06.035","article-title":"The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report","volume":"91","author":"Azziz","year":"2009","journal-title":"Fertil. Steril."},{"issue":"9","key":"10.1016\/j.steroids.2017.08.007_b0270","doi-asserted-by":"crossref","first-page":"3400","DOI":"10.1210\/jc.2015-2123","article-title":"Androgen profile through life in women with polycystic ovary syndrome: a Nordic multicenter collaboration study","volume":"100","author":"Pinola","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.steroids.2017.08.007_b0275","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1210\/jc.2002-021875","article-title":"Beyond adrenal and ovarian androgen generation: increased peripheral 5\u03b1-reductase activity in women with polycystic ovary syndrome","volume":"88","author":"Fassnacht","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.steroids.2017.08.007_b0280","doi-asserted-by":"crossref","first-page":"4085","DOI":"10.1210\/jc.2006-0227","article-title":"Variants in the 5\u03b1-reductase type 1 and type 2 genes are associated with polycystic ovary syndrome and the severity of hirsutism in affected women","volume":"91","author":"Goodarzi","year":"2006","journal-title":"Endocrinol. Metab."},{"key":"10.1016\/j.steroids.2017.08.007_b0285","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1095\/biolreprod66.2.297","article-title":"Elevated endometrial androgen receptor expression in women with polycystic ovarian syndrome","volume":"66","author":"Apparao","year":"2002","journal-title":"Biol. Reprod."},{"issue":"4","key":"10.1016\/j.steroids.2017.08.007_b0290","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1093\/humrep\/dei420","article-title":"The association between polycystic ovaries and endometrial cancer","volume":"21","author":"Pillay","year":"2006","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.steroids.2017.08.007_b0295","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.1093\/humrep\/del183","article-title":"Expression of molecules associated with tissue homeostasis in secretory endometria from untreated women with polycystic ovary syndrome","volume":"21","author":"Avellaira","year":"2006","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.steroids.2017.08.007_b0300","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.ygyno.2006.09.003","article-title":"Deregulation of tissue homeostasis in endometria from patients with polycystic ovarian syndrome with and without endometrial hyperplasia","volume":"104","author":"Villavicencio","year":"2007","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.steroids.2017.08.007_b0305","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ygyno.2009.06.033","article-title":"Involvement of Akt, Ras and cell cycle regulators in the potential development of endometrial hyperplasia in women with polycystic ovarian syndrome","volume":"115","author":"Villavicencio","year":"2009","journal-title":"Gynecol. Oncol."},{"issue":"2","key":"10.1016\/j.steroids.2017.08.007_b0310","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/S0015-0282(03)00987-7","article-title":"Expression of steroid receptors and proteins related to apoptosis in endometria of women with polycystic ovary syndrome","volume":"80","author":"Maliqueo","year":"2003","journal-title":"Fertil. Steril."},{"issue":"1","key":"10.1016\/j.steroids.2017.08.007_b9030","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1530\/REP-10-0056","article-title":"Role of the transcriptional factors FOXO1 and PPARG on gene expression of SLC2A4 in endometrial tissue from women with polycystic ovary syndrome","volume":"140","author":"Kohan","year":"2010","journal-title":"Reproduction"},{"key":"10.1016\/j.steroids.2017.08.007_b0315","first-page":"1","article-title":"Endometria from obese PCOS women with hyperinsulinemia exhibit altered adiponectin signaling","volume":"47","author":"Garc\u00eda","year":"2015","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.steroids.2017.08.007_b0320","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/j.1365-2265.2005.02256.x","article-title":"Prevalence of adrenal androgen excess in patients with the polycystic ovary syndrome (PCOS)","volume":"62","author":"Kumar","year":"2005","journal-title":"Clin. Endocrinol."},{"issue":"1","key":"10.1016\/j.steroids.2017.08.007_b0325","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.steroids.2006.05.005","article-title":"Steroidogenic alterations and adrenal androgen excess in PCOS","volume":"7","author":"Doi","year":"2006","journal-title":"Steroids"},{"key":"10.1016\/j.steroids.2017.08.007_b0330","doi-asserted-by":"crossref","first-page":"4683","DOI":"10.1007\/s00216-015-8670-x","article-title":"Serum metabolomics study of polycystic ovary syndrome based on UPLC-QTOF-MS coupled with a pattern recognition approach","volume":"407","author":"Dong","year":"2015","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.steroids.2017.08.007_b0335","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jsbmb.2014.06.003","article-title":"DHEA, DHEAS and PCOS","volume":"145","author":"Goodarzi","year":"2015","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.steroids.2017.08.007_b0340","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.steroids.2010.06.011","article-title":"The conversion of dehydroepiandrosterone into androst-5-ene-3\u03b2,17\u03b2-diol (androstenediol) is increased in endometria from untreated women with polycystic ovarian syndrome","volume":"75","author":"Plaza","year":"2010","journal-title":"Steroids"},{"key":"10.1016\/j.steroids.2017.08.007_b0345","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.steroids.2007.09.003","article-title":"Activities of steroid metabolic enzymes in secretory endometria from untreated women with Polycystic Ovary Syndrome","volume":"73","author":"Leon","year":"2008","journal-title":"Steroids"},{"key":"10.1016\/j.steroids.2017.08.007_b0350","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jsbmb.2008.03.031","article-title":"In situ estrogen metabolism in proliferative endometria from untreated women with polycystic ovarian syndrome with and without endometrial hyperplasia","volume":"110","author":"Bacallao","year":"2008","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.steroids.2017.08.007_b0355","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.steroids.2015.10.001","article-title":"Expression of steroid sulfated transporters and 3\u03b2-HSD activity in endometrium of women having polycystic ovary syndrome","volume":"104","author":"Plaza-Parrochia","year":"2015","journal-title":"Steroids"},{"key":"10.1016\/j.steroids.2017.08.007_b0360","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jsbmb.2003.10.011","article-title":"The proliferative effects of 5-androstene-3\u03b2,17\u03b2-diol and 5\u03b1-dihydrotestosterone on cell cycle analysis and cell proliferation in MCF7, T47D and MDAMB231 breast cancer cell lines","volume":"88","author":"Aspinall","year":"2004","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.steroids.2017.08.007_b0365","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1111\/j.1349-7006.2011.02018.x","article-title":"Sex steroid hormones in pairs of tumor and serum from breast cancer patients and pathobiological role of androstene-3\u03b2, 17\u03b2-diol","volume":"102","author":"Honma","year":"2011","journal-title":"Cancer Sci."},{"key":"10.1016\/j.steroids.2017.08.007_b0370","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.steroids.2012.07.014","article-title":"3D models of human ERa and ERb complexed with 5-androsten-3\u03b2,17\u03b2-diol","volume":"77","author":"Baker","year":"2012","journal-title":"Steroids"},{"key":"10.1016\/j.steroids.2017.08.007_b0375","first-page":"1","article-title":"Molecular mechanisms of androstenediol in the regulation of the proliferative process of human endometrial cells","author":"Plaza-Parrochia","year":"2016","journal-title":"Reprod. Sci."},{"issue":"2","key":"10.1016\/j.steroids.2017.08.007_b0380","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1177\/1933719115597762","article-title":"Levels of regulatory proteins associated with cell proliferation in endometria from untreated patients having polycystic ovarian syndrome with and without endometrial hyperplasia","volume":"23","author":"Bacallao","year":"2016","journal-title":"Reprod. Sci."},{"key":"10.1016\/j.steroids.2017.08.007_b0385","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.1210\/jcem.82.10.4306","article-title":"Effect of 12-month dehydroepiandrosterone replacement therapy on bone, vagina, and endometrium in postmenopausal women","volume":"82","author":"Labrie","year":"1997","journal-title":"Clin. Endocrinol. Metab."},{"key":"10.1016\/j.steroids.2017.08.007_b0390","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.coph.2003.07.006","article-title":"Clinical uses and misuses of dehydroepiandrosterone","volume":"3","author":"Binello","year":"2003","journal-title":"Curr. Opin. Pharmacol."},{"issue":"7","key":"10.1016\/j.steroids.2017.08.007_b0395","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1210\/er.2007-0019","article-title":"Androgen receptor (AR) coregulators: a diversity of functions converging on and regulating the AR transcriptional complex","volume":"28","author":"Heemers","year":"2007","journal-title":"Endocr. Rev."},{"issue":"3","key":"10.1016\/j.steroids.2017.08.007_b0400","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1152\/physrev.00026.2006","article-title":"Estrogen receptors: how do they signal and what are their targets","volume":"87","author":"Heldring","year":"2007","journal-title":"Physiol. Rev."},{"issue":"6","key":"10.1016\/j.steroids.2017.08.007_b0405","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.1210\/jcem.87.6.8572","article-title":"Steroid receptor coactivator expression throughout the menstrual cycle in normal and abnormal endometrium","volume":"87","author":"Gregory","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.steroids.2017.08.007_b0410","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.fertnstert.2005.09.053","article-title":"Evaluation of steroid receptors, coregulators, and molecules associated with uterine receptivity in secretory endometria from untreated women with polycystic ovary syndrome","volume":"85","author":"Quezada","year":"2006","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.steroids.2017.08.007_b0415","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ygyno.2006.03.029","article-title":"Androgen and estrogen receptors and co-regulators levels in endometria from patients with polycystic ovarian syndrome with and without endometrial hyperplasia","volume":"103","author":"Villavicencio","year":"2006","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.steroids.2017.08.007_b0420","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijgo.2014.10.022","article-title":"Systematic review of cell adhesion molecules and estrogen receptor expression in the endometrium of patients with polycystic ovary syndrome","volume":"129","author":"Baracat","year":"2015","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"10.1016\/j.steroids.2017.08.007_b0425","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.steroids.2015.09.004","article-title":"Molecular profiling of estrogen receptor a and progesterone receptor transcript variants in endometrial cancer","volume":"104","author":"Skrzypczak","year":"2015","journal-title":"Steroids"},{"issue":"11","key":"10.1016\/j.steroids.2017.08.007_b9035","first-page":"869","article-title":"Absence of progesterone receptors in a failed case of fertility-sparing treatment in early endometrial cancer: a case report","volume":"53","author":"Hoekstra","year":"2008","journal-title":"J. Reprod. Med."},{"key":"10.1016\/j.steroids.2017.08.007_b0430","first-page":"1023","article-title":"Up-regulation of Nuclear Receptor Corepressor (NCoR) in progestin-induced growth suppression of endometrial hyperplasia and carcinoma","volume":"29","author":"Kashima","year":"2009","journal-title":"Anticancer Res."},{"key":"10.1016\/j.steroids.2017.08.007_b0435","first-page":"387","article-title":"Analysis of the status of the novel estrogen receptor \u03b1 (ER\u03b1) coactivator p72 in endometrial cancer and its cross talk with erbB-2 in the transactivation of ER\u03b1","volume":"1","author":"Zhao","year":"2008","journal-title":"Mol. Med. Rep."}],"container-title":["Steroids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X17301393?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X17301393?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,2]],"date-time":"2019-10-02T11:40:06Z","timestamp":1570016406000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039128X17301393"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":95,"alternative-id":["S0039128X17301393"],"URL":"https:\/\/doi.org\/10.1016\/j.steroids.2017.08.007","relation":{},"ISSN":["0039-128X"],"issn-type":[{"value":"0039-128X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Endometrium and steroids, a pathologic overview","name":"articletitle","label":"Article Title"},{"value":"Steroids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.steroids.2017.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}